Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

vTv Therapeutics Inc. - Class A Common Stock (NQ:VTVT)

15.30 UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about vTv Therapeutics Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >
VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress
vTv Therapeutics reports Q2 2025 loss of $0.92 per share, missing estimates. Revenue at $0 as expected. Shares rise slightly amid focus on Phase 3 diabetes trial progress. 
Via Chartmill
This Couchbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges
vTv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month timeline to accelerate key studies. 
Via Benzinga
VTVT Stock Earnings: vTv Therapeutics Reported Results for Q2 2024
vTv Therapeutics just reported results for the second quarter of 2024. 
Via InvestorPlace
VTVT Stock Earnings: vTv Therapeutics Reported Results for Q1 2024
vTv Therapeutics just reported results for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Dow Edges Lower; Ventyx Biosciences Shares Plummet
 
Via Benzinga
Topics Stocks
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
 
Via Benzinga
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
 
Via Benzinga
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
vTv Therapeutics faces a setback as the FDA places a clinical hold on its cadisegliatin program, impacting the CATT1 Phase 3 trial for type 1 diabetes. 
Via Benzinga
Nasdaq Gains 1%; McDonald's Posts Downbeat Results
 
Via Benzinga
Why Is LuxUrban Hotels (LUXH) Stock Down 12% Today?
LuxUrban Hotels stock is down on Monday after the company priced a public offering of LUXH shares below its prior closing price. 
Via InvestorPlace
Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?
VTv Therapeutics stock is falling on Monday as VTVT investors react to the company's cadisegliatin clinical program being put on hold. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning! 
Via InvestorPlace
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy. 
Via InvestorPlace
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The... 
Via Benzinga
Topics Stocks
Why Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today?
vTv Therapeutics stock surge, fueled by a $51M private placement. Learn about their clinical-stage biopharmaceutical focus on cadisegliatin for type 1 diabetes. Stock up 111.8% at $18. 
Via Benzinga
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
The company reported in-line sales for the fourth quarter, but shares soared by double digits. 
Via Investor's Business Daily
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded down 0.19% to 38,899.92 while the NASDAQ fell 0.31% to 15,985.25. The... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sal 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers on Tuesday with a breakdown of all the latest news affecting shares this morning. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.